Orient Europharma Co Ltd (4120) — Cash Flow Reinvestment Rate
Orient Europharma Co Ltd (4120) has a Cash Flow Reinvestment Rate of 44.08x as of June 2025, reinvesting NT$1.47 Billion (capex NT$89.03 Million plus investments NT$1.38 Billion) from operating cash flow of NT$33.25 Million. Check 4120 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Orient Europharma Co Ltd Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Orient Europharma Co Ltd across 8 annual periods. Explore investment intensity of Orient Europharma Co Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Orient Europharma Co Ltd (2015–2023)
Year-by-year capital reinvestment analysis for Orient Europharma Co Ltd. For live market cap and broader valuation context, see 4120 company net worth.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.44x | NT$351.83 Million | NT$64.67 Million | NT$100.70 Million | ▼ -75.1% |
| 2021 | 21.89x | NT$1.70 Billion | NT$77.65 Million | NT$1.56 Billion | ▲ +3647.9% |
| 2020 | 0.58x | NT$355.35 Million | NT$608.55 Million | NT$232.78 Million | ▲ +4.4% |
| 2019 | 0.56x | NT$127.14 Million | NT$227.37 Million | NT$124.98 Million | ▼ -36.0% |
| 2018 | 0.87x | NT$202.21 Million | NT$231.31 Million | NT$201.61 Million | ▲ +9.7% |
| 2017 | 0.80x | NT$478.86 Million | NT$601.08 Million | NT$367.66 Million | ▼ -85.4% |
| 2016 | 5.47x | NT$608.30 Million | NT$111.24 Million | NT$224.81 Million | ▲ +912.9% |
| 2015 | 0.54x | NT$347.66 Million | NT$643.97 Million | NT$229.54 Million | — |